Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2014
Q3
$19K Buy
700
+600
+600% +$16.6K ﹤0.01% 8094
2014
Q2
$3K Hold
100
﹤0.01% 9885
2014
Q1
$2K Buy
+100
New +$1.95K ﹤0.01% 10086

Other funds holding LDL

UBS's LDL Position: Q3 2014 in Review

UBS reduced its Lydall, Inc. (LDL) stake by 55% in Q3 2014, selling an estimated $70.8K and leaving 2,104 shares worth $57K. The position accounts for ﹤0.01% of the portfolio, ranked #6675.

UBS first reported a position in LDL in Q2 2013 and has held it in 6 quarters since. The position peaked at $127K in Q2 2014. 120 funds tracked by Wall St. Rank hold LDL as of Q3 2014.

  • UBS held 2,104 shares of Lydall, Inc. worth $57K as of Q3 2014.
  • UBS sold 2,556 Lydall, Inc. shares in Q3 2014, an estimated $70.8K.
  • Lydall, Inc. made up ﹤0.01% of UBS's portfolio in Q3 2014, its #6675 holding.
  • UBS first reported a position in Lydall, Inc. in Q2 2013 and has held it in 6 quarters since.
  • UBS's Lydall, Inc. position peaked at $127K in Q2 2014.
  • 120 funds tracked by Wall St. Rank held Lydall, Inc. as of Q3 2014.

Based on UBS's 13F filing for Q3 2014, filed 12 Nov 2014.